LEAP-2
LEAP-2 (Human liver expressed antimicrobial peptide-2) is a GHS-R1a antagonist, with an IC50 of 6.0 nM. LEAP-2 suppresses the orexigenic effect of ghrelin. LEAP-2 attenuates ghrelin-induced growth hormone (GH) release and reduces basal food intake. LEAP-2 exhibits antimicrobial activity against microbial model organisms. LEAP-2 can be used for the study of obesity and infection[1][2].
Product Specifications
CAS Number
[1683582-94-6]
Product Name Alternative
Human liver expressed antimicrobial peptide-2
UNSPSC
12352209
Target
Bacterial; GHSR; IFNAR; Interleukin Related; TNF Receptor
Type
Peptides
Related Pathways
Anti-infection; Apoptosis; GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Infection; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/leap-2.html
Purity
97.64
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C191H316N64O57S5
Molecular Weight
4581.27
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
GHSR1a
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items